期刊
AMERICAN JOURNAL OF THERAPEUTICS
卷 17, 期 2, 页码 197-200出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MJT.0b013e3181a6ee1c
关键词
anabolic therapy; antiresorptive therapy; RANK ligand; osteoporosis
The existing drugs for treatment of osteoporosis are limited in scope, tolerability, and efficacy. Newer osteoclast-targeted agents like inhibitors of receptor activator nuclear factor kappa B pathway, Cathepsin K, and integrins are under clinical development. Osteoblast-targeted therapies include the agents acting through the Wnt signaling pathway like sclerostin antagonists. The potential molecular targets and the emerging drugs for treatment of osteoporosis are discussed in this review.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据